loadpatents
name:-0.028053045272827
name:-0.025352954864502
name:-0.0059099197387695
DISIS; Mary L. Patent Filings

DISIS; Mary L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for DISIS; Mary L..The latest application filed is for "breast and ovarian cancer vaccines".

Company Profile
6.25.25
  • DISIS; Mary L. - Renton WA
  • Disis; Mary L. - Seattle WA
  • Disis; Mary L - Renton WA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Breast And Ovarian Cancer Vaccines
App 20220040275 - DISIS; Mary L. ;   et al.
2022-02-10
Breast and ovarian cancer vaccines
Grant 11,185,578 - Disis , et al. November 30, 2
2021-11-30
Breast And Ovarian Cancer Vaccines
App 20210346480 - DISIS; Mary L. ;   et al.
2021-11-11
Breast and ovarian cancer vaccines
Grant 11,160,853 - Disis , et al. November 2, 2
2021-11-02
Cancer vaccine compositions and methods of use thereof
Grant 10,759,836 - Disis , et al. Sep
2020-09-01
Methods And Materials For Expanding Antigen-specific T Cells In Culture
App 20200248140 - Kind Code
2020-08-06
Methods and materials for expanding antigen-specific T cells in culture
Grant 10,647,961 - Cohen , et al.
2020-05-12
Breast And Ovarian Cancer Vaccines
App 20200054725 - Disis; Mary L. ;   et al.
2020-02-20
HLA-DR binding peptides and their uses
Grant 10,556,943 - Knutson , et al. Feb
2020-02-11
Breast and ovarian cancer vaccines
Grant 10,293,035 - Disis , et al.
2019-05-21
Methods And Vaccines For Inducing Immune Responses To Multiple Different Mhc Molecules
App 20190000948 - McCurry; Dustin B. ;   et al.
2019-01-03
Methods And Materials For Expanding Antigen-specific T Cells In Culture
App 20180245042 - Cohen; Peter A. ;   et al.
2018-08-30
Hla-dr Binding Peptides And Their Uses
App 20170342126 - Knutson; Keith L. ;   et al.
2017-11-30
Cancer Vaccine Compositions And Methods Of Use Thereof
App 20170283475 - DISIS; Mary L. ;   et al.
2017-10-05
Methods Of Identifying Antigens For Vaccines
App 20170266269 - DISIS; Mary L. ;   et al.
2017-09-21
Breast And Ovarian Cancer Vaccines
App 20170182137 - DISIS; Mary L. ;   et al.
2017-06-29
Compositions And Methods For The Diagnosis And Treatment Of Breast Cancer
App 20160209414 - Disis; Mary L. ;   et al.
2016-07-21
Molecules and methods for treatment and detection of cancer
Grant 9,060,961 - Disis , et al. June 23, 2
2015-06-23
Hla-dr Binding Peptides And Their Uses
App 20140377340 - Knutson; Keith L. ;   et al.
2014-12-25
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
Grant 8,524,491 - Cheever , et al. September 3, 2
2013-09-03
Diagnostic panel of cancer antibodies and methods for use
Grant 8,216,789 - Disis , et al. July 10, 2
2012-07-10
Hla-dr Binding Peptides And Their Uses
App 20100310640 - Knutson; Keith L. ;   et al.
2010-12-09
Molecules And Methods For Treatment And Detection Of Cancer
App 20100092523 - Disis; Mary L. ;   et al.
2010-04-15
Immune Reactivity To Her-2/neu Protein For Diagnosis And Treatment Of Malignancies In Which The Her-2/neu Oncogene Is Associated
App 20100087621 - Cheever; Martin A. ;   et al.
2010-04-08
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
Grant 7,655,239 - Cheever , et al. February 2, 2
2010-02-02
COMPOUNDS FOR ELICITING OR ENHANCING IMMUNE REACTIVITY TO HER-2/neu PROTEIN FOR PREVENTION OR TREATMENT OF MALIGNANCIES IN WHICH THE HER-2/neu ONCOGENE IS ASSOCIATED
App 20100010075 - CHEEVER; Martin A. ;   et al.
2010-01-14
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
Grant 7,601,697 - Cheever , et al. October 13, 2
2009-10-13
Diagnostic Panel Of Cancer Antibodies And Methods For Use
App 20090215091 - Disis; Mary L. ;   et al.
2009-08-27
Surface receptor antigen vaccines
Grant 7,547,681 - Scholler , et al. June 16, 2
2009-06-16
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
App 20080076904 - Cheever; Martin A. ;   et al.
2008-03-27
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
Grant 7,247,703 - Cheever , et al. July 24, 2
2007-07-24
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
App 20060008479 - Cheever; Martin A. ;   et al.
2006-01-12
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
Grant 6,953,573 - Cheever , et al. October 11, 2
2005-10-11
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
Grant 6,942,862 - Cheever , et al. September 13, 2
2005-09-13
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
App 20050191285 - Cheever, Martin A. ;   et al.
2005-09-01
Surface receptor antigen vaccines
App 20040219161 - Scholler, Nathalie B. ;   et al.
2004-11-04
Surface receptor antigen vaccines
Grant 6,734,172 - Scholler , et al. May 11, 2
2004-05-11
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
App 20040082758 - Cheever, Martin A. ;   et al.
2004-04-29
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
Grant 6,664,370 - Cheever , et al. December 16, 2
2003-12-16
Surface Receptor Antigen Vaccines
App 20030008342 - Scholler, Nathalie B. ;   et al.
2003-01-09
Immune Reactivity To Her-2/neu Protein For Diagnosis And Treatment Of Malignancies In Which The Her-2/neu Oncogene Is Associated
App 20020055614 - CHEEVER, MARTIN A ;   et al.
2002-05-09
Methods And Compositions To Generate Immunity In Humans Against Self Tumor Antigens By Immunization With Homologous Foreign Proteins
App 20020019331 - CHEEVER, MARTIN A ;   et al.
2002-02-14
Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
Grant 6,180,114 - Yager , et al. January 30, 2
2001-01-30
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
Grant 5,876,712 - Cheever , et al. March 2, 1
1999-03-02
Methods for eliciting or enhancing reactivity to HER-2/neu protein
Grant 5,869,445 - Cheever , et al. February 9, 1
1999-02-09
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
Grant 5,846,538 - Cheever , et al. December 8, 1
1998-12-08
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
Grant 5,801,005 - Cheever , et al. September 1, 1
1998-09-01
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
Grant 5,726,023 - Cheever , et al. March 10, 1
1998-03-10
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed